The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery

YANG Bo; ZHANG Qingsong; WANG Beibei; NI Fangfang; ZHANG Ying; HAN Shuqi

doi:10.16766/j.cnki.issn.1674-4152.003541

Volume 22 Issue 6

Jun. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Chinese Journal of General Practice > 2024 > 22(6): 947-950

YANG Bo, ZHANG Qingsong, WANG Beibei, NI Fangfang, ZHANG Ying, HAN Shuqi. The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery[J]. Chinese Journal of General Practice, 2024, 22(6): 947-950. doi: 10.16766/j.cnki.issn.1674-4152.003541

Citation:

YANG Bo, ZHANG Qingsong, WANG Beibei, NI Fangfang, ZHANG Ying, HAN Shuqi. The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery[J]. Chinese Journal of General Practice, 2024, 22(6): 947-950. doi: 10.16766/j.cnki.issn.1674-4152.003541

Citation:

YANG Bo, ZHANG Qingsong, WANG Beibei, NI Fangfang, ZHANG Ying, HAN Shuqi. The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery[J]. Chinese Journal of General Practice, 2024, 22(6): 947-950. doi: 10.16766/j.cnki.issn.1674-4152.003541

PDF( 399 KB)

The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery

doi: 10.16766/j.cnki.issn.1674-4152.003541

Department of Gynecology and oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233004, China

Funds:

2023AH051982

Received Date: 2024-03-06
Available Online: 2024-07-22

Abstract

Abstract

Objective To investigate the prognostic impact of lymph node ratio (LNR) on 2018 International Federation of Gynaecology and Obstetrics Stage ⅢC1p cervical cancer patients. Methods A total of 89 patients with lymph node-positive cervical cancer from January 2014 to December 2017 in the Oncology Department of the First Affiliated Hospital Bengbu Medical University underwent radical hysterectomy and systematic pelvic lymphadenectomy with or without abdominal aortic dissection. All patients received concurrent chemoradiotherapy. LNR was defined as the ratio of positive lymph nodes to the total number of LNS removed. Patients were divided into 2 groups according to LNR; LNR < 0.06(42 cases) and LNR≥0.06 (47 cases). The prognostic value of LNR was assessed by univariate log-rank test and multivariable Cox regression models. Results The median follow-up was 44.6 months (range, 6-115 months), and the 5-year disease-free survival (DFS) rate for the entire cohort was 61.6%, while the 5-year overall survival (OS) rate was 69.7%. The 5-year DFS rates for LNR < 0.06 and LNR≥0.06 were 65.4% and 54.2%, respectively (P=0.027). Furthermore, the 5-year OS rates for LNR < 0.06 and LNR≥0.06 were 82.8% and 59.6%, respectively (P=0.003). In multivariable analysis, LNR≥0.06 was associated with worse DFS (HR=2.040, 95% CI: 1.130-3.870, P=0.013) and OS (HR=1.940, 95% CI: 1.020-3.780, P=0.038). Conclusion LNR≥0.06 may be an independent prognostic factor for decreased DFS and OS in patients with stage ⅢC1P cervical cancer.
- Cervical cancer,
- Lymph node ratio,
- Stage ⅢC1p,
- Prognostic analysis

FullText(HTML)

References(17)

References

[1]	WANG M T, MA M, YANG L J, et al. Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer[J]. Front Oncol, 2022, 12: 952347. DOI: 10.3389/fonc.2022.952347.
[2]	ASLAN K, MEYDANLI M M, OZ M, et al. The prognostic value of lymph node ratio in stage ⅢC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy[J]. J Gynecol Oncol, 2020, 31(1): e1. DOI: 10.3802/jgo.2020.31.e1.
[3]	WIDSCHWENDTER P, POLASIK A, JANNI W, et al. Lymph node ratio can better predict prognosis than absolute number of positive lymph nodes in operable cervical carcinoma[J]. Oncol Res Treat, 2020, 43(3): 87-95. doi: 10.1159/000505032
[4]	龙行涛, 周琦, 王冬, 等. 子宫颈癌2018年FIGO新分期ⅢC期患者预后分析[J]. 中国癌症杂志, 2021, 31(8): 725-733. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202108005.htm LONG X T, ZHOU Q, WANG D, et al. The prognostic value of revised 2018 FIGO stageⅢC in cervical cancer[J]. China Oncology, 2021, 31(8): 725-733. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ202108005.htm
[5]	RYU J M, CHOI Y S, BAE J Y. Prognostic factors in women with cervical cancer stage ⅢC1r treated with concurrent chemoradiotherapy[J]. J Obstet Gynaecol Res, 2020, 46(7): 1165-1172. doi: 10.1111/jog.14305
[6]	FEMANDES A, VIVEROS-CARREÑO D, HOEGL J, et al. Human papillomavirus-independent cervical cancer[J]. Int J Gynecol Cancer, 2022, 32(1): 1-7. doi: 10.1136/ijgc-2021-003014
[7]	XU J, MA Y L, MEI H B, et al. Diagnostic value of multimodal magnetic resonance imaging in discriminating between metastatic and non-metastatic pelvic lymph nodes in cervical cancer[J]. Int J Gen Med, 2022, 15: 6279-6288. doi: 10.2147/IJGM.S372154
[8]	TOHYAMA A, MURAKAMI M, YOSHINO K. Strategies for the treatment of cervical cancer with bulky pelvic lymph nodes: an overview of the current evidence[J]. J UOEH, 2020, 42(4): 317-325. doi: 10.7888/juoeh.42.317
[9]	张慧慧, 王蓓蓓, 张献文, 等. 伴有盆腔淋巴结转移的宫颈癌新辅助化疗联合放化疗临床疗效及预后因素分析[J]. 中华全科医学, 2021, 19(11): 1823-1826, 1839. doi: 10.16766/j.cnki.issn.1674-4152.002176 ZHANG H H, WANG B B, ZHANG X W, et al. Treatment effect and analysis of prognostic factors of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for advanced cervical cancer with pelvic lymph node metastasis[J]. Chinese Journal of General Practice, 2021, 19(11): 1823-1826, 1839. doi: 10.16766/j.cnki.issn.1674-4152.002176
[10]	OLTHOF E P, MOM C H, SNIJDERS M L H, et al. The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer[J]. Acta Obstet Gynecol Scand, 2022, 101(5): 550-557. doi: 10.1111/aogs.14316
[11]	JIN C, LI J, ZOU C X, et al. Lymph node ratio predicts prognosis in patients with surgically resected invasive pancreatic cystic neoplasms[J]. Transl Cancer Res, 2020, 9(10): 5843-5856. doi: 10.21037/tcr-20-1355
[12]	SUPSAMUTCHAI C, WILASRUSMEE C, JIRASIRITHAM J, et al. Recurrence outcome of lymph node ratio in gastric cancer after underwent curative resection: a retrospective cohort study[J]. Ann Med Surg (Lond), 2020, 54: 57-61. doi: 10.1016/j.amsu.2020.04.002
[13]	SAKIN A, ALDEMTR M N. Lymph node ratio predicts long-term survival in lymph node-positive breast cancer[J]. Eur J Breast Health, 2020, 16(4): 270-275. doi: 10.5152/ejbh.2020.5809
[14]	余淼, 冉立, 常建英, 等. 淋巴结转移和淋巴结阳性比率对早期宫颈癌预后的影响分析[J]. 中国临床医生杂志, 2020, 48(6): 733-736. doi: 10.3969/j.issn.2095-8552.2020.06.033 YU M, RAN L, CHANG J Y, et al. Analysis of the influence of lymph node metastasis and lymph node positive ratio on prognosis of early cervical cancer[J]. Chinese Journal For Clinicians, 2020, 48(6): 733-736. doi: 10.3969/j.issn.2095-8552.2020.06.033
[15]	KIM S I, KIM T H, LEE M, et al. Lymph node ratio is a strong prognostic factor in patients with early-stage cervical cancer undergoing minimally invasive radical hysterectomy[J]. Yonsei Med J, 2021, 62(3): 231-239. doi: 10.3349/ymj.2021.62.3.231
[16]	BOGANI G, VINTI D, MuRGIA F, et al. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage ⅢCp cervical cancer[J]. Int J Gynecol Cancer, 2019, 29(9): 1355-1360. doi: 10.1136/ijgc-2019-000669
[17]	FAN X, WANG Y F, YANG N, et al. Prognostic analysis of patients with stage ⅢC1p cervical cancer treated by surgery[J]. World J Surg Oncol, 2023, 21(1): 186. doi: 10.1186/s12957-023-03076-9

Relative Articles

[1]	WANG Yu, CHEN Fangfang, WANG Chao, GUO Han, WANG Suhang, LIU Mulin. Value of c-MYC expression in a lymph node metastasis risk prediction model for colon cancer[J]. Chinese Journal of General Practice, 2024, 22(3): 372-375. doi: 10.16766/j.cnki.issn.1674-4152.003405
[2]	WANG Mengge, LI Man, CHANG Yuhuan, LYU Lili, YE Guoliu. Predictive value of HIST1H3D in lymph node metastasis of early cervical cancer[J]. Chinese Journal of General Practice, 2023, 21(6): 940-944. doi: 10.16766/j.cnki.issn.1674-4152.003020
[3]	HATILA Tuerxun, MIKRBAN Tursun, LIU Qian, LI Jin-qiu, ALFIRA Abdujapar, AYSHAMGUL Hasim. Expression and significance of CD8⁺ T cells and NK cells in peripheral blood of patients with cervical cancer[J]. Chinese Journal of General Practice, 2022, 20(8): 1299-1301. doi: 10.16766/j.cnki.issn.1674-4152.002581
[4]	GAO Long-fei, LIU Jian. Prognostic analysis of different treatments for locally advanced cervical cancer[J]. Chinese Journal of General Practice, 2022, 20(3): 395-398. doi: 10.16766/j.cnki.issn.1674-4152.002361
[5]	WANG Chao, MEI Zhi-jie, CAO Zhen-xue, LIANG Yu-jie, CHEN Meng-jie, ZHANG Yong-qi, GUO Yuan-yuan, YANG Xiao-huai. Study on the inhibitory effects of miR-140-5p targeting YES1 proto-oncogene[J]. Chinese Journal of General Practice, 2021, 19(5): 731-735. doi: 10.16766/j.cnki.issn.1674-4152.001903
[6]	LI Hu, ZHU Yong-shi, WANG Ning-ning, GUO Shao-yong, CHEN Zhi-jun. miR-200C-3p inhibit the proliferation and migration of prostate cancer cells via targeting ZEB2[J]. Chinese Journal of General Practice, 2021, 19(11): 1846-1850. doi: 10.16766/j.cnki.issn.1674-4152.002182
[7]	ZHANG Hui-hui, WANG Bei-bei, ZHANG Xian-wen, WANG Li-hua, WEI Li, LI Yan, ZHANG Jing. Treatment effect and analysis of prognostic factors of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for advanced cervical cancer with pelvic lymph node metastasis[J]. Chinese Journal of General Practice, 2021, 19(11): 1823-1826, 1839. doi: 10.16766/j.cnki.issn.1674-4152.002176
[8]	XU Jie, GAO Long-fei, DENG Zhao-ya, LIU Jian. Analysis of pathological characteristics and prognosis of stages ⅠB1 and ⅡA2 cervical squamous cell carcinoma and adenocarcinoma[J]. Chinese Journal of General Practice, 2021, 19(5): 812-816. doi: 10.16766/j.cnki.issn.1674-4152.001924
[9]	LIU Jian, DENG Zhao-ya, XU Jie, GAO Long-fei, SUN Yi-lin, LI Yan. Clinical analysis of modified laparoscopic extensive hysterectomy in the treatment of stage ⅠA2 - ⅠB1 cervical cancer[J]. Chinese Journal of General Practice, 2021, 19(7): 1117-1120. doi: 10.16766/j.cnki.issn.1674-4152.001999
[10]	PAN Ru-jing, ZHANG Li, LIN Xiao-hua, LI Zhi-ming, LIU Jing-jing. Analysis of prognostic factors for Merkel cell carcinoma based on SEER database[J]. Chinese Journal of General Practice, 2020, 18(6): 1030-1034. doi: 10.16766/j.cnki.issn.1674-4152.001420
[11]	WANG Hui, ZHANG Hui-fang, ZHOU Jin-qiang, LI Na, LI Yang, CUI Hui-zhuan, WANG Xuan-jiu. Study on the correlation between Ki-67, P53 and CA153 and axillary lymph node metastasis of breast cancer[J]. Chinese Journal of General Practice, 2019, 17(9): 1518-1520. doi: 10.16766/j.cnki.issn.1674-4152.000985
[12]	LOU Gong-xian, LOU Shi-xian, CHENG Miao-yuan, SU Ai-fang, LI Yi-pei, XU Ling-yan. Analysis of the application value combined detection of FBG, HbA1c, TC and TG in diagnosis of GDM in early pregnancy[J]. Chinese Journal of General Practice, 2019, 17(5): 809-812. doi: 10.16766/j.cnki.issn.1674-4152.000798
[13]	ZHAO Xiao-ying, ZHENG Hu-zhong, JIN Wei-wei, . Correlation between clinicopathological features and pelvic lymph node metastasis in cervical cancer[J]. Chinese Journal of General Practice, 2019, 17(3): 430-432. doi: 10.16766/j.cnki.issn.1674-4152.000700
[14]	LI Hang, PAN Zhi-jian, WU Wei, . Risk factors and prognosis of vascular invasion in patients with T1a-T1b gastric cancer[J]. Chinese Journal of General Practice, 2019, 17(3): 367-369,387. doi: 10.16766/j.cnki.issn.1674-4152.000683
[15]	ZHAO Jian-pei, DAI Xiao-yu, XIE Yang-yang. The expression and clinical significance of Beclin1 and p62 in colon cancer tissue[J]. Chinese Journal of General Practice, 2017, 15(5): 773-775,826. doi: 10.16766/j.cnki.issn.1674-4152.2017.05.013
[16]	DU Jun-jun, ZHANG Hong-fang, ZHOU Rong-jing. Application analysis of VEGF and Rsf-1 in pathologic diagnosis[J]. Chinese Journal of General Practice, 2017, 15(11): 1849-1851. doi: 10.16766/j.cnki.issn.1674-4152.2017.11.008
[17]	LU Jie, WU Xiao-jie, ZHU Wei-li. Factors affecting pelvic lymph node metastasis and prognosis of patients undergoing radical surgery for cervical cancer[J]. Chinese Journal of General Practice, 2017, 15(2): 270-273. doi: 10.16766/j.cnki.issn.1674-4152.2017.02.027
[18]	ZHANG Li-ping. Survival analysis of IMRT in recurrent endometrial carcinoma[J]. Chinese Journal of General Practice, 2016, 14(11): 1863-1866. doi: 10.16766/j.cnki.issn.1674-4152.2016.11.023
[20]	YU Jian-qin, ZHOU Qing, WANG Han-chu, ZHENG Fei-yun, CHEN Zhi-wen. The expression of astrocyte elevated gene-1(AEG-1) in cervical cancer and it's correlation with angiogenesis[J]. Chinese Journal of General Practice, 2016, 14(5): 796-798,853. doi: 10.16766/j.cnki.issn.1674-4152.2016.05.034

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (171) PDF downloads(8)

The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery

doi: 10.16766/j.cnki.issn.1674-4152.003541

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery

doi: 10.16766/j.cnki.issn.1674-4152.003541

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content